share_log
Hi,
moomoo ID:0
Log Out
English
Back
  • English
  • 中文繁体
  • 中文简体

Apollo Medical (NASDAQ:AMEH) Now Covered by Analysts at William Blair

Defense World ·  09/23 13:31

Equities researchers at William Blair assumed coverage on shares of Apollo Medical (NASDAQ:AMEH – Get Rating) in a research note issued to investors on Wednesday, MarketBeat.com reports. The brokerage set an "outperform" rating on the stock.

Separately, Barclays lifted their price objective on Apollo Medical from $50.00 to $57.00 and gave the company an "equal weight" rating in a report on Monday, August 8th.

Get Apollo Medical alerts:

Apollo Medical Stock Down 2.7 %

Shares of AMEH opened at $40.58 on Wednesday. The firm has a market capitalization of $2.29 billion, a P/E ratio of 25.36 and a beta of 0.75. Apollo Medical has a 12-month low of $29.52 and a 12-month high of $133.23. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.41. The firm has a fifty day moving average price of $46.80 and a 200-day moving average price of $42.49.

Institutional Investors Weigh In On Apollo Medical

A number of large investors have recently bought and sold shares of AMEH. Nisa Investment Advisors LLC raised its stake in shares of Apollo Medical by 285.7% during the 2nd quarter. Nisa Investment Advisors LLC now owns 810 shares of the company's stock worth $31,000 after buying an additional 600 shares during the period. FMR LLC raised its stake in Apollo Medical by 36.1% in the 2nd quarter. FMR LLC now owns 1,067 shares of the company's stock valued at $41,000 after purchasing an additional 283 shares during the last quarter. Quantbot Technologies LP acquired a new position in Apollo Medical in the 2nd quarter valued at $54,000. Lazard Asset Management LLC acquired a new stake in shares of Apollo Medical in the 1st quarter worth $66,000. Finally, PNC Financial Services Group Inc. increased its stake in shares of Apollo Medical by 49.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company's stock worth $75,000 after acquiring an additional 520 shares during the last quarter. Hedge funds and other institutional investors own 32.03% of the company's stock.

Apollo Medical Company Profile

(Get Rating)

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Further Reading

  • Get a free copy of the StockNews.com research report on Apollo Medical (AMEH)
  • What Steelcase's Earnings Say About the Return to the Office?
  • The Institutions Hold On To Darden Restaurants International
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Is The Golden Age Of Homebuilding Already Over?
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.